Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders
Open Access
- 1 May 2013
- journal article
- research article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 7, 411-417
Abstract
Background: Lamotrigine is an anticonvulsant drug indicated for the maintenance treatment of bipolar I disorder and for various types of epilepsy. An orally disintegrating tablet (ODT) of lamotrigine was developed to provide a formulation option that might increase patient convenience and satisfaction. Methods: Subjects with mood disorders who reported difficulty swallowing currently prescribed lamotrigine immediate-release medication (baseline) were enrolled and treated with lamotrigine ODT for three weeks (end of treatment). Subject satisfaction and convenience were measured using the Treatment Satisfaction Questionnaire for Medication (TSQM). Also measured were global psychopathology using the Clinical Global Impression severity index (CGI-S) and depressive symptoms using the Beck Depression Inventory (BDI-II). Results: Lamotrigine ODT was found to be significantly more convenient to use than lamotrigine immediate-release (change in baseline TSQM convenience score: 23.3, n = 97, P < 0.001). The mean TSQM global satisfaction score was similar at baseline (76.3) and after treatment with lamotrigine ODT (76.0). There were no significant changes on CGI-S and BDI-II. Conclusion: Subjects reported that lamotrigine ODT was significantly more convenient than lamotrigine immediate-release, while both formulations were associated with good satisfaction. Lamotrigine ODT may be a treatment option for patients who have difficulty swallowing medication.Keywords
This publication has 31 references indexed in Scilit:
- Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus GuidelinesJournal of Psychiatric Practice, 2010
- The Prevalence of Dysphagia in Primary Care Patients: A HamesNet Research Network StudyThe Journal of the American Board of Family Medicine, 2007
- Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronateCurrent Medical Research and Opinion, 2006
- Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and olderInternational Journal of Geriatric Psychiatry, 2006
- Prevalence of Dysphagia in Acute and Community Mental Health SettingsDysphagia, 2006
- Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapineJournal of Psychopharmacology, 2005
- Adherence to MedicationNew England Journal of Medicine, 2005
- Swallowing Disorders in the ElderlyThe Laryngoscope, 2002
- Special issues in the treatment of paediatric bipolar disorderExpert Opinion on Pharmacotherapy, 2001
- Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984Epilepsia, 1993